Lymphoma, Large-Cell, Anaplastic
"Lymphoma, Large-Cell, Anaplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS.
| Descriptor ID |
D017728
|
| MeSH Number(s) |
C04.557.386.480.750.399 C15.604.515.569.480.750.600 C20.683.515.761.480.750.399
|
| Concept/Terms |
Lymphoma, Large-Cell, Anaplastic- Lymphoma, Large-Cell, Anaplastic
- CD30-Positive Anaplastic Large-Cell Lymphoma
- CD30 Positive Anaplastic Large Cell Lymphoma
- Ki-1 Lymphoma
- Ki 1 Lymphoma
- Ki-1 Lymphomas
- Lymphoma, Ki-1
- Lymphomas, Ki-1
- Systemic Anaplastic Large-Cell Lymphoma
- Systemic Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Anaplastic Large-Cell Lymphomas
- Large-Cell Lymphoma, Anaplastic
- Large-Cell Lymphomas, Anaplastic
- Lymphoma, Anaplastic Large-Cell
- Lymphomas, Anaplastic Large-Cell
- CD30+ Anaplastic Large-Cell Lymphoma
- CD30+ Anaplastic Large Cell Lymphoma
- Lymphoma, Large-Cell, Ki-1
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Large-Cell, Anaplastic".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, Large-Cell, Anaplastic [C04.557.386.480.750.399]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, Large-Cell, Anaplastic [C15.604.515.569.480.750.600]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, Large-Cell, Anaplastic [C20.683.515.761.480.750.399]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Large-Cell, Anaplastic".
This graph shows the total number of publications written about "Lymphoma, Large-Cell, Anaplastic" by people in this website by year, and whether "Lymphoma, Large-Cell, Anaplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 2 | 1 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, Large-Cell, Anaplastic" by people in Profiles.
-
Advances and updates in pediatric anaplastic large cell lymphoma. Blood Adv. 2025 Oct 14; 9(19):4870-4880.
-
Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era. Blood Adv. 2025 Mar 25; 9(6):1356-1365.
-
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma. Front Immunol. 2023; 14:1203471.
-
Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. Haematologica. 2022 08 01; 107(8):1880-1890.
-
A Right Atrial Mass with Fever and Cutaneous Nodules. Methodist Debakey Cardiovasc J. 2022; 18(1):48-53.
-
Lack of Evidence on Complication Profile of Breast Implant Capsulectomy: A Call to Action for Plastic Surgeons. Plast Reconstr Surg. 2021 Jul 01; 148(1):157e-158e.
-
Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK?+?LBCL): a systematic review of clinicopathological features and management. Leuk Lymphoma. 2021 12; 62(12):2845-2853.
-
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212). Cancer Chemother Pharmacol. 2020 12; 86(6):829-840.
-
Insights into the Microbiome of Breast Implants and Periprosthetic Tissue in Breast Implant-Associated Anaplastic Large Cell Lymphoma. Sci Rep. 2019 07 17; 9(1):10393.
-
Allogeneic hematopoietic cell transplant following crizotinib monotherapy for relapsed/refractory anaplastic large cell lymphoma. Pediatr Transplant. 2018 08; 22(5):e13210.